NB-001 in Children and Adolescents With 22q11 Deletion Syndrome

Clinical trial NCT05290493 · COMPLETED

Trial details

NCT number: NCT05290493
Sponsor: Nobias Therapeutics, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

22q11 Deletion Syndrome

Start date: 2022-02-10
Primary completion: 2023-06-01
Enrollment: 37

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.